Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Licensing opportunity from RCT: VZV subunit vaccine

Jan. 14, 1999

First vaccine for Lyme disease now available from SB in the U.S.

Jan. 13, 1999

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Jan. 13, 1999

SangStat continues to progress with generic ciclosporin formulations

Jan. 12, 1999

Peptide immunomodulators available for licensing from Peptech

Jan. 12, 1999

Eisai prepares novel digalactosylceramide derivatives for multiple indications

Jan. 11, 1999

Mycophenolate mofetil potentiates antiherpesvirus activity of aciclovir

Jan. 8, 1999

FDA clears new product for preventing kidney transplant rejection

Jan. 5, 1999

New indications for Prograf scheduled for FDA advisory committee review

Dec. 30, 1998

Ono-4057 useful in organ transplants according to results presented at Japanese congress

Dec. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...